Quick Answer
Arteris, Inc. reported R&D Expense of $49.91 million for fiscal year 2025.
Arteris, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $49.91M | +10.9% |
| 2024 | $45.01M | -0.3% |
| 2023 | $45.13M | +9.6% |
| 2022 | $41.17M | +33.6% |
| 2021 | $30.81M | +81.0% |
| 2020 | $17.02M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.65M | +6.1% | +3.9% |
| June 30, 2025 | $12.17M | +13.6% | +2.6% |
| March 31, 2025 | $11.86M | +9.5% | -0.5% |
| September 30, 2024 | $11.92M | +8.4% | +11.3% |
| June 30, 2024 | $10.72M | -11.3% | -1.1% |
| March 31, 2024 | $10.84M | -4.8% | -1.5% |
| September 30, 2023 | $11.00M | -0.2% | -9.0% |
| June 30, 2023 | $12.09M | +16.5% | +6.2% |
- Arteris, Inc. showed an increase of +10.9% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, Arteris, Inc.’s r&d expense has grown by 193.2% (from $17.02 million to $49.91 million).
- The most recent figure is from Arteris, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: